UK Medical Devices Market Size, Share, Trends & Forecast by Type, End User and Region, 2025-2033

The UK medical devices market size reached USD 18,008.9 Million in 2024 and is projected to grow to USD 30,893.9 Million by 2033. The market is expected to expand at a CAGR of 6.18% during the forecast period 2025-2033, driven by advancements in healthcare technology, an aging population, increased healthcare spending, and rising adoption of digital health technologies.

Study Assumption Years

Base Year: 2024
Historical Year/Period: 2019-2024
Forecast Year/Period: 2025-2033

UK Medical Devices Market Key Takeaways

The UK medical devices market size was USD 18,008.9 Million in 2024.
The market is expected to grow at a CAGR of 6.18% during 2025-2033.
The forecast period covers 2025-2033.
The market growth is driven by advancements in healthcare technology and growing focus on personalized treatments.
Increasing adoption of digital health solutions like telemedicine, mobile applications, and wearable devices supports market expansion.
The NHS promotes AI-based diagnostic tools accelerating the evaluation and adoption of advanced medical devices.
Demand for home-based medical devices is rising due to the aging population and decentralization of healthcare services.

Sample Request Link:
https://www.imarcgroup.com/uk-medical-devices-market/requestsample

Market Growth Factors

The UK medical devices market growth is significantly driven by ongoing advancements in healthcare technology accompanied by rising healthcare expenditure. The increasing aging population, with over 18.6% aged 65 years and older, fuels demand for specialized medical devices. Furthermore, a growing focus on personalized treatment approaches and prevention promotes the development of advanced medical devices, particularly those integrated with digital health technologies like AI-enhanced wearables, which help manage chronic diseases.

The shift toward digital health integration is a major growth factor. The rise of telemedicine and mobile health applications has created demand for devices facilitating remote monitoring and diagnostics. The adoption of wearable technologies such as smartwatches and fitness trackers has expanded into healthcare realms, particularly for managing diabetes, hypertension, and respiratory disorders. Around 38% of the UK population has used health apps, influenced by consumer demand and government initiatives for better patient outcomes and cost efficiencies.

Growth in diagnostic imaging is another key factor, with 45.0 million imaging tests conducted in England in 2023, representing a 2.2% increase from 44.0 million in 2022. Significant investment in innovations like MRI, CT scans, and ultrasound by the NHS aims to improve diagnostic capabilities, reduce backlogs, and provide timely treatment. This sector's advancements enhance the overall efficiency and effectiveness of the UK healthcare system.

Market Segmentation

Type Insights:

Orthopedic Devices
Cardiovascular Devices
Diagnostic Imaging: Driven by increased imaging tests and innovations in MRI, CT, and ultrasound technologies enhancing diagnostic accuracy.
In-vitro Diagnostics (IVD)
Minimally Invasive Surgery (MIS)
Wound Management
Diabetes Care
Ophthalmic Devices
Dental Devices
Nephrology
General Surgery
Others

End User Insights:

Hospitals & ASCs
Clinics
Others

Regional Insights

The UK medical devices market covers major regions including London, South East, North West, East of England, South West, Scotland, West Midlands, Yorkshire and The Humber, East Midlands, and others. The report details these regional markets providing a comprehensive analysis but does not specify a dominant region or exact market share percentages. The overall national market growth is supported by widespread adoption and investment across these regions.

Recent Developments & News

On 9 January 2024, Abbott launched Lingo in the UK, a biowearable gadget and software that provides real-time glucose monitoring and personalized health insights to improve well-being. On 30 January 2023, the UK Focused Ultrasound Foundation (UK FUSF) was formally launched to advance focused ultrasound technology, which offers non-invasive treatment guided by real-time imaging, eliminating the need for incisions or radiation.

Ask for Report Customization:
https://www.imarcgroup.com/request?type=report&id=24944&flag=E

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

Contact Us
IMARC Group,
134 N 4th St. Brooklyn, NY 11249, USA,
Email: sales@imarcgroup.com,
Tel No: (D) +91 120 433 0800,
United States: +1-201971-6302

IMARC Group is a global management consulting firm that helps the world's most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

This release was published on openPR.